 SOLANA BEACH, Calif., Sept. 06, 2022 GLOBE NEWSWIRE -- Evoke Pharma, Inc. NASDAQ: EVOK, a specialty pharmaceutical company focused primarily on treatments for gastrointestinal GI diseases, today announced that the Companys President and CEO, David A. Gonyer, R.Ph., and Chief Business Officer, Matt DOnofrio, MBA, will present at the H.C. Wainwright 24th Annual Global Investment Conference taking place from September 12-14, 2022, at the Lotte New York Palace Hotel in NYC. 